The new oral antiviral agents for COVID-19

• Príomhchruthaitheoirí: S.L. Seneviratne (Údar), C. Dalugama (Údar), P. Madanayake (Údar), B. Samaraweera (Údar), J. Kariyawasam (Údar), V. Abeysuriya (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Sri Lanka College of Internal Medicine, 2022-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Coronavirus Disease-2019 (COVID-19), has so far affected more than 275 million individuals globally and caused over 5.3 million deaths. With an effective vaccine, disease and infection could be prevented, whereas with antivirals and monoclonal antibodies, disease progression could be mitigated. In r...